Overview
Prostate cancer screening is the process of testing for the presence of prostate cancer before symptoms occur. Prostate cancer is very common among men, and it can be difficult to diagnose due to its slow-growing nature. Screening can help detect the disease at an early stage, allowing for better treatment options and improved survival rates. Several tests are available for prostate cancer screening, including the prostate-specific antigen (PSA) test, digital rectal exam (DRE), and prostate biopsy. Early detection of prostate cancer can improve a patient's chances of successful treatment, and can also reduce the risk of complications and the need for more extensive treatment.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Markers for Significant or High-Grade Prostate Cancer in Patients over 75 Years Undergoing Prostatic Biopsy
Drug Design Progress of In silico, In vitro and In vivo Researches
How this research is being cited
The 3 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
V. Zaichick · 2023 · Archives of Epidemiology & Public Health Research
-
V. Zaichick · 2022 · Comprehensive Research and Reviews in Medicine and Dentistry
-
2020 · Journal of Cancer Therapy
-
2020 · American Journal of Biomedical Science & Research
-
2020 · Iberoamerican Journal of Medicine
-
V. Zaichick · 2020 ·
-
V. Zaichick et al. · 2020 · International Journal of Medical Sciences
-
2019 · Journal of Analytical & Pharmaceutical Research
A sample of recent works citing this journal's research on Screening for Prostate Cancer, linking to each citing work.